News

Stay up-to-date on ReadyCell’s latest news, projects and developments.

Caco-2 based in vitro models for the screening of anti-inflammatory drugs

Caco-2 based in vitro models for the screening of anti-inflammatory drugs

Inflammatory reactions of the intestinal tract are the result of a combination of hereditary, genetic and/or environmental factors that have been clustered in the inflammatory bowel disease (IBD). ReadyCell has available CacoReady and CacoGoblet to assay compounds inflammatory properties.

Cell-based in vitro models to characterize Food-Drug Interactions

Cell-based in vitro models to characterize Food-Drug Interactions

It is well known that food intake changes luminal conditions (e.g. pH, motility, microbiota,…) in the stomach and the small intestine, modifying drugs bioavailability. Food-drug interactions are one of the major challenges for oral-administered drugs, even more so if considering the growing use of food supplements and functional foods.

Job offer: Digital Communications Officer

Job offer: Digital Communications Officer

To be successful in this role, you will need a deep understanding of the pharmaceutical industry. You will also need excellent written communication skills. An outstanding candidate will be someone whose expertise translates into increased brand awareness and profitability.

1000 CacoReady batches

1000 CacoReady batches

Congratulations to the manufacturing department for the comitmment and expertize in cell culture.

ReadyCell is expanding boundaries

ReadyCell is expanding boundaries

The cell-based in vitro kits are shipped to South America, ensuring the quality standards. The patented biotechnology Shipping Medium® and the specialized logistic procedure at room temperature, achieve the proper delivery despite the long distances. ReadyCell is constantly growing and reaching out to more and more countries around the world.